Insilicos

Insilicos combines advanced laboratory measurements with new data analysis approaches, to derive powerful insights into health and disease. Insilicos' biomarker research is primarily directed towards development of diagnostics for cardiovascular disease. PreClue, our first diagnostic test, is the subject of an ongoing clinical study. We make extensive use of cloud computing approaches. As early adopters of cloud computing, we have contributed to educational workshops and conducted consulting and custom programming projects related to cloud computing, including cloud-based proteomics and ensemble-learning and migrating analyses using the R language into the cloud. Our extensive background in proteomics data analysis includes analysis of large studies and of novel techniques.